Literature DB >> 1252327

Oestradiol synthesis from C19 steroids by human breast cancers.

W R Miller, A P Forrest.   

Abstract

Entities:  

Keywords:  Androgens; Biology; Breast Cancer; Cancer; Clinical Research; Diseases; Endocrine System; Estradiol--analysis; Estrogens; Hormones; In Vitro; Neoplasms; Physiology; Research Methodology; Stanolone--analysis; Testosterone--analysis

Mesh：

Substances：

Year:  1976        PMID： 1252327      PMCID： PMC2024907          DOI： 10.1038/bjc.1976.13

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  7 in total

1.  Steroid metabolism by human breast and rat mammary carcinomata.

Authors:  W R Miller; A P Forrest; T Hamilton
Journal:  Steroids       Date:  1974-03       Impact factor: 2.668

2.  Oestradiol synthesis by a human breast carcinoma.

Authors:  W R Miller; A P Forrest
Journal:  Lancet       Date:  1974-10-12       Impact factor: 79.321

3.  Metabolism of androgens by human breast tissue.

Authors:  W R Miller; D McDonald; A P Forrest; A A Shivas
Journal:  Lancet       Date:  1973-04-28       Impact factor: 79.321

4.  Metabolism of testosterone by human breast tumours.

Authors:  J S Jenkins; S Ash
Journal:  Lancet       Date:  1972-09-09       Impact factor: 79.321

5.  Steroid metabolism by human breast tumours.

Authors:  D Jones; E H Cameron; K Griffiths; E N Gleave; A P Forrest
Journal:  Biochem J       Date:  1970-03       Impact factor: 3.857

6.  Further studies on the relationship between C19- and C21-steroid synthesis in the human adrenal gland.

Authors:  E H Cameron; T Jones; D Jones; A B Anderson; K Griffiths
Journal:  J Endocrinol       Date:  1969-10       Impact factor: 4.286

7.  Serum oestradiol-17 beta in women with benign and malignant breast disease.

Authors:  P C England; L G Skinner; K M Cottrell; R A Sellwood
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640
  7 in total
  12 in total

1.  Aromatase in breast cancer tissue--localization and relationship with reproductive status of patients.

Authors:  L M Berstein; A A Larionov; A Sh Kyshtoobaeva; K M Pozharisski; V F Semiglazov; O A Ivanova
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. Ireland, 6-8 July, 1988. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

3.  Correlation of aromatase activity with histological differentiation of breast cancer--a morphometric analysis.

Authors:  A Lipton; R J Santen; S J Santner; H A Harvey; D White-Hershey; M J Bartholomew; F E Sharkey
Journal:  Breast Cancer Res Treat       Date:  1988-09       Impact factor: 4.872

Review 4.  Aromatase inhibitors in the treatment of postmenopausal breast cancer.

Authors:  E Bajetta; N Zilembo; E Bichisao
Journal:  Drugs Aging       Date:  1999-10       Impact factor: 3.923

Review 5.  Progress in understanding breast cancer: epidemiological and biological interactions.

Authors:  P Boyle; R Leake
Journal:  Breast Cancer Res Treat       Date:  1988-05       Impact factor: 4.872

Review 6.  Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.

Authors:  Paul E Goss; Kathrin Strasser
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  [The influence of endogenous hormones on the oestrogen and progesterone receptor determination in tissue of mammary carcinoma (author's transl)].

Authors:  H Caffier; H Brandau
Journal:  Arch Gynakol       Date:  1978-07-19

8.  Detection of intratumoral aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation.

Authors:  J M Esteban; Z Warsi; M Haniu; P Hall; J E Shively; S Chen
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

9.  Proceedings of the British Association for Cancer Research. University of Glasgow 28--30 March 1979. Abstracts.

Authors: 
Journal:  Br J Cancer       Date:  1979-08       Impact factor: 7.640

10.  Inhibition of aromatase activity and expression in MCF-7 cells by the chemopreventive retinoid N-(4-hydroxy-phenyl)-retinamide.

Authors:  H P Ciolino; T T Wang; N Sathyamoorthy
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.